| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1485094A1 FORM OF PRESENTATION FOR 3- (2-{ 4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO -METHYL}-1-METHYL-1iH /i -BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO PROPIONIC ACID ETHYL ESTER TO BE ADMINISTERED ORALLY |
| 12/15/2004 | EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
| 12/15/2004 | EP1485091A1 Thiazole and oxazole derivatives that modulate ppar activity |
| 12/15/2004 | EP1485090A2 Combinations comprising epothilone derivatives and alkylating agents |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 12/15/2004 | EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 12/15/2004 | EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists |
| 12/15/2004 | EP1485085A1 Phosphate prodrugs of fluorooxindoles |
| 12/15/2004 | EP1485084A1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophtalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/15/2004 | EP1485082A1 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
| 12/15/2004 | EP1485081A1 Ibuprofen solution for hard shell capsules |
| 12/15/2004 | EP1485080A1 Use of adapalene for the treatment of dermatological disorders |
| 12/15/2004 | EP1485079A2 Small molecule entry inhibitors |
| 12/15/2004 | EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes |
| 12/15/2004 | EP1485077A1 Drug combination therapy |
| 12/15/2004 | EP1485076A1 Therapeutic methods for acute myeloid leukemia |
| 12/15/2004 | EP1485074A2 Compositions for treating digestive functional pathologies |
| 12/15/2004 | EP1485072A1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion. |
| 12/15/2004 | EP1485071A2 Compressed tablets comprising microcapsules with modified release |
| 12/15/2004 | EP1485070A1 Pharmaceutical microparticles |
| 12/15/2004 | EP1485059A1 Topical dapsone for the treatment of acne |
| 12/15/2004 | EP1485057A2 Derivatives of azaspiro compounds for the treatment of pain |
| 12/15/2004 | EP1485051A1 Method of administering buprenorphine to treat depression |
| 12/15/2004 | EP1485050A2 A substance with sedative effect |
| 12/15/2004 | EP1485042A1 Medical devices for delivering anti-proliferative compositions to anatomical sites at risk of restenosis |
| 12/15/2004 | EP1485040A1 Method of administering an injectable antibiotic to the ear of an animal |
| 12/15/2004 | EP1484977A2 Compositions and methods for treating mdma-induced toxicity |
| 12/15/2004 | EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 12/15/2004 | EP1484966A2 Derivatives of isoflavones |
| 12/15/2004 | EP1436285A4 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 12/15/2004 | EP1430033A4 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 12/15/2004 | EP1414470A4 Micronutrient phosphates as dietary and health supplements |
| 12/15/2004 | EP1409476B1 Pharmaceutical compounds with serotonin receptor activity |
| 12/15/2004 | EP1406496A4 Method and composition for enhancing sexual desire |
| 12/15/2004 | EP1399155A4 Small molecules useful in the treatment of inflammatory disease |
| 12/15/2004 | EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 12/15/2004 | EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 12/15/2004 | EP1373216B1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/15/2004 | EP1368303B1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 12/15/2004 | EP1357932B1 Crystal modification of a cyclic depsipeptide having improved strength |
| 12/15/2004 | EP1322301B1 Combination particles for the treatment of asthma |
| 12/15/2004 | EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients |
| 12/15/2004 | EP1320533A4 Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
| 12/15/2004 | EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 12/15/2004 | EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 12/15/2004 | EP1301517B1 Thienopyrrolidinones |
| 12/15/2004 | EP1294371B1 Medium chain fatty acids applicable as antimicrobial agents |
| 12/15/2004 | EP1284267B1 Triazole compounds having amide linkage |
| 12/15/2004 | EP1283056B1 Medicinal compositions promoting bowel movement |
| 12/15/2004 | EP1278742B1 Chromenylmethylpyrimidinediamines as antibacterial agents |
| 12/15/2004 | EP1263711B1 Novel use of phenylheteroalkylamine derivatives |
| 12/15/2004 | EP1249245B1 Remedies and/or preventives for nervous system disorders |
| 12/15/2004 | EP1238159B1 Tissue products containing antiviral agents which are mild to the skin |
| 12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 12/15/2004 | EP1226122B1 Bicyclic vasopressin agonists |
| 12/15/2004 | EP1221937B1 Hybrid matrices and hybrid matrix mixtures |
| 12/15/2004 | EP1218005B1 Vitronectin receptor antagonists |
| 12/15/2004 | EP1183038A4 Plant preparation containing phenethylisothiocyanate |
| 12/15/2004 | EP1176963B1 Use of dopamine d 3 receptor antagonists for producing medicaments for treating kidney disorders |
| 12/15/2004 | EP1158957A4 Liquid suppository composition of diclofenac sodium |
| 12/15/2004 | EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 12/15/2004 | EP1128838A4 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 12/15/2004 | EP1126841B1 Combinations of a 5ht1b/1d agonist and a selective cox-2 inhibitor for the treatment of migraine |
| 12/15/2004 | EP1124545B1 Use of 2-methoxyestradiol as anti-fungal agents |
| 12/15/2004 | EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 12/15/2004 | EP1115295A4 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
| 12/15/2004 | EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
| 12/15/2004 | EP1073704B1 Stable carbanilide composition |
| 12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 12/15/2004 | EP1047415B1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 12/15/2004 | EP1030547B1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients |
| 12/15/2004 | EP1025211B1 Hyaluronan synthase gene and uses thereof |
| 12/15/2004 | EP1015022B1 New improved formulation for treatment of thromboembolism |
| 12/15/2004 | EP0969816B1 Preparation of powder agglomerates |
| 12/15/2004 | EP0938304B1 Isovaleramide for the treatment of convulsions, epilepsy, headache and spasticity |
| 12/15/2004 | EP0929323B1 Implantable acrylamide copolymer hydrogel for therapeutic uses |
| 12/15/2004 | EP0921785B1 Combination of acid protease enzymes and acidic buffers and uses thereof |
| 12/15/2004 | EP0900796B1 Preventives and remedies for ischemic intestinal lesion and ileus |
| 12/15/2004 | EP0884051B1 Cancerous metastasis inhibitors containing uracil derivatives |
| 12/15/2004 | EP0863755B1 Antithrombotic diamines |
| 12/15/2004 | EP0837874B1 Neuroactive steroids of the androstane and pregnane series |
| 12/15/2004 | EP0788507B1 L-pyranosyl nucleosides |
| 12/15/2004 | EP0630252B1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases |
| 12/15/2004 | CN1555487A A process for the isolation of a major harmful oxidant from cigarette smoke |
| 12/15/2004 | CN1555389A Oral-use polymer and oral-use composition |
| 12/15/2004 | CN1555385A Ligands to enhance cellular uptake of biomolecules |
| 12/15/2004 | CN1555382A Association compound of trehalose or maltitol with metal ion compound |
| 12/15/2004 | CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 12/15/2004 | CN1555377A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 12/15/2004 | CN1555376A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 12/15/2004 | CN1555375A Compounds for inhibiting the release of inflammatory cytokines |
| 12/15/2004 | CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives |
| 12/15/2004 | CN1555370A Process for the preparation of 5-substituted isobenzofurans |
| 12/15/2004 | CN1555367A 3-substituted-4-pyrimidone derivatives |
| 12/15/2004 | CN1555365A N-aminoimidazole derivative for inhibiting HIV |
| 12/15/2004 | CN1555361A Butyric acid derivatives |